Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 441 results found. Search for [ Oxford University - AstraZeneca ]

Results 1 to 21 of 441
PTI
June 19, 2021
Professor Andrew Pollard noted that in India, the vast majority of the population is unvaccinated and, therefore, unprotected at a time when the Delta variant is a widespread and increasing threat


PTI
June 10, 2021
The increased risk of the condition, known as idiopathic thrombocytopenic purpura (ITP), is estimated to be 11 per million doses, according to researchers at the University of Edinburgh, UK


Reuters
May 20, 2021
Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine rollouts, generating a lot of data about the use of the shots in real world settings


PTI
May 18, 2021
The government last week extended the gap between two doses of the Covishield COVID-19 vaccine to 12-16 weeks, up from the previous maximum of eight weeks, on the recommendation of the NTAGI


PTI
May 16, 2021
A leading UK scientist who advises the country's vaccination programme said on Saturday that vaccines being administered to protect against COVID-19 are \"almost certainly less effective\" against preventing the transmission of the B1.617.2 variant first identified in India


PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


PTI
May 1, 2021
Gen Shavendra Silva, chief of COVID prevention operations, said supply is being delayed from the Serum Institute of India in the wake of the current COVID crisis in the country


Reuters
April 30, 2021
This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of its vaccine, which it developed with Oxford University


BusinessToday.In
April 24, 2021
Addressing the scepticism over Covishield prices, Poonawalla said there was an inaccurate comparison between global prices of the vaccine with India, adding that it is the cheapest COVID-19 vaccine available


PTI
April 24, 2021
Odds of new SARS-CoV-2 infection were reduced 65 per cent in those 21 days since first vaccination with no second dose versus unvaccinated individuals without evidence of prior infection, the Oxford University study noted


BusinessToday.In
New Delhi, April 19, 2021
A modified version of AstraZeneca's COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday; Former prime minister Manmohan Singh on Sunday wrote to Prime Minister Narendra Modi on the COVID-19 crisis, stressing that ramping up vaccination was the key to battling the pandemic; China will expand digital yuan experiments to more cities, but there is no specific timetable for its official rollout. China is one of the frontrunners in the global race to launch central bank digital currencies to modernise financial systems. Watch this and more on News Blast.Also Read: Oxford University to reinfect recovered Covid-19 patients to develop better vaccines


Reuters
April 19, 2021
Sarah Walters, AstraZeneca's Austria country manager said so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were \"too small to draw final conclusions\"


PTI
April 16, 2021
The research found that the rare blood clotting known as Cerebral Venous Thrombosis (CVT) is more common after Covid-19 than in any of the comparison groups, with 30 per cent of these cases occurring in the under 30s


Reuters
April 15, 2021
The United Kingdom launched its inoculation drive in December and has already offered a first shot to all over-50s, the clinically vulnerable and health workers


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


Reuters
April 9, 2021
The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would \"very shortly apply for permission to conduct clinical bridging trials in India,\" according to the report


Rashi Bisaria
New Delhi, April 9, 2021
Australia, Philippines, African Union ban AstraZeneca's COVID-19 shotAustralia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world. The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concerns and supply problems since Phase III tria...


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


PTI
April 9, 2021
A growing number of countries have either halted or limited the use of the AstraZeneca coronavirus vaccine recently over fears that it can cause serious blood clots


Reuters
April 9, 2021
The Philippines suspended the use of AstraZeneca shots for people under age 60 after Europe's regulator said on Wednesday it found rare cases of blood clots among some adult recipients, although it still believes that the vaccine's benefits outweighed its risks


PAGES 1 OF 23  12345